Several recent studies from UC Berkeley have rekindled the hope of curing an HIV infection by luring it out of its latent state, making treatment much more effective. The labs of Qiang Zhou and Jim Hurley, professors in the Department of Molecular and Cellular Biology, have been leading the efforts to investigate this new approach to treating HIV.
University of California, Berkeley, researchers have described 10 new CRISPR enzymes that, once activated, behave like Pac-Man to chew up RNA in a way that could be used as sensitive detectors of infectious viruses.
The University of California, the University of Vienna and Emmanuelle Charpentier (collectively UC) on Wednesday, April 12, filed an appeal to overturn a decision by the Patent Trial and Appeal Board (PTAB) that terminated the interference between a UC patent application for CRISPR-Cas9 gene-editing technology and the patent applications and issued patents of the Broad Institute, Harvard University and the Massachusetts Institute of Technology.
A new PBS Nature documentary explores the impact of climate change on Yosemite National Park, and features two UC Berkeley biologists who climb to the tops of giant sequoias to understand what the future holds for these ancient trees.
Professor Nipam Patel is working on different ways to generate color in a lab setting. Research on colorful phenomena has inspired many technologies, from sensors to drug treatments, and has provided a glimpse into nature’s inner workings, from evolution to quantum physics.
In a paper appearing today in the journal PLOS Biology, researchers at the University of California, Berkeley, and Pfizer Worldwide Research and Development report finding a small molecule that was able to block the production of a specific protein involved in LDL (low-density lipoprotein) turnover by stalling only the ribosome that produces that protein.